Prime Movers Lab is a Wyoming-based early-stage venture capital firm focused on breakthrough science and hard technology. It invests in companies reinventing major sectors such as energy, infrastructure, human augmentation, and advanced manufacturing. Compared with mainstream venture firms, it is unusually explicit about backing deep scientific platforms with transformative ambition.

Its neurotech practice is tied closely to the human augmentation thesis, with portfolio companies including Paradromics and Cognixion. These investments reflect a strong commitment to BCI, EEG-based interfaces, and communication technologies for severe neurological impairment. Prime Movers Lab stands out as a firm that is comfortable backing neurotechnology not just as healthcare, but as a frontier human-machine platform.

The firm invests primarily in the United States, while maintaining broad reach into science-based innovation globally. For neurotech founders, it is especially relevant to companies in BCI, assistive interfaces, and high-ambition neuroengineering. It is one of the more thesis-aligned firms for breakthrough neural interface technologies.